Taken together our data indicated that exosomal AREG induces the activation of EGFR pathway that increases, in pre-osteoclasts treated with NSCLC-exosomes, the expression of RANKL at mRNA and protein levels. This evidence concerns the gene EGFR and non-small cell lung carcinoma.